Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: A4HDS1
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 68 | 72 | PF00656 | 0.563 |
CLV_NRD_NRD_1 | 289 | 291 | PF00675 | 0.629 |
CLV_NRD_NRD_1 | 294 | 296 | PF00675 | 0.622 |
CLV_NRD_NRD_1 | 60 | 62 | PF00675 | 0.434 |
CLV_PCSK_FUR_1 | 287 | 291 | PF00082 | 0.604 |
CLV_PCSK_KEX2_1 | 287 | 289 | PF00082 | 0.640 |
CLV_PCSK_KEX2_1 | 293 | 295 | PF00082 | 0.619 |
CLV_PCSK_PC7_1 | 289 | 295 | PF00082 | 0.643 |
CLV_PCSK_SKI1_1 | 198 | 202 | PF00082 | 0.689 |
CLV_PCSK_SKI1_1 | 61 | 65 | PF00082 | 0.446 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.598 |
DOC_MAPK_DCC_7 | 274 | 283 | PF00069 | 0.707 |
DOC_MAPK_gen_1 | 274 | 283 | PF00069 | 0.707 |
DOC_MAPK_MEF2A_6 | 274 | 283 | PF00069 | 0.707 |
DOC_MAPK_MEF2A_6 | 87 | 96 | PF00069 | 0.402 |
DOC_PP2B_LxvP_1 | 281 | 284 | PF13499 | 0.719 |
DOC_PP2B_LxvP_1 | 96 | 99 | PF13499 | 0.439 |
DOC_PP4_FxxP_1 | 223 | 226 | PF00568 | 0.516 |
DOC_USP7_MATH_1 | 147 | 151 | PF00917 | 0.563 |
DOC_USP7_MATH_1 | 196 | 200 | PF00917 | 0.636 |
DOC_USP7_MATH_1 | 217 | 221 | PF00917 | 0.641 |
DOC_USP7_MATH_1 | 244 | 248 | PF00917 | 0.739 |
DOC_WW_Pin1_4 | 263 | 268 | PF00397 | 0.758 |
DOC_WW_Pin1_4 | 8 | 13 | PF00397 | 0.665 |
LIG_14-3-3_CanoR_1 | 117 | 122 | PF00244 | 0.625 |
LIG_14-3-3_CanoR_1 | 13 | 19 | PF00244 | 0.525 |
LIG_14-3-3_CanoR_1 | 204 | 213 | PF00244 | 0.699 |
LIG_BRCT_BRCA1_1 | 219 | 223 | PF00533 | 0.519 |
LIG_Clathr_ClatBox_1 | 121 | 125 | PF01394 | 0.535 |
LIG_eIF4E_1 | 80 | 86 | PF01652 | 0.366 |
LIG_FHA_1 | 19 | 25 | PF00498 | 0.540 |
LIG_FHA_1 | 205 | 211 | PF00498 | 0.748 |
LIG_FHA_2 | 206 | 212 | PF00498 | 0.566 |
LIG_LIR_Apic_2 | 220 | 226 | PF02991 | 0.589 |
LIG_LIR_Gen_1 | 130 | 139 | PF02991 | 0.475 |
LIG_LIR_Gen_1 | 183 | 191 | PF02991 | 0.493 |
LIG_LIR_Gen_1 | 55 | 65 | PF02991 | 0.421 |
LIG_LIR_Nem_3 | 130 | 134 | PF02991 | 0.390 |
LIG_LIR_Nem_3 | 183 | 188 | PF02991 | 0.487 |
LIG_LIR_Nem_3 | 55 | 60 | PF02991 | 0.400 |
LIG_MYND_1 | 95 | 99 | PF01753 | 0.441 |
LIG_NRBOX | 155 | 161 | PF00104 | 0.606 |
LIG_PALB2_WD40_1 | 119 | 127 | PF16756 | 0.534 |
LIG_SH2_CRK | 140 | 144 | PF00017 | 0.496 |
LIG_SH2_CRK | 26 | 30 | PF00017 | 0.536 |
LIG_SH2_STAP1 | 20 | 24 | PF00017 | 0.582 |
LIG_SH2_STAT3 | 104 | 107 | PF00017 | 0.428 |
LIG_SH2_STAT5 | 104 | 107 | PF00017 | 0.410 |
LIG_SH2_STAT5 | 20 | 23 | PF00017 | 0.559 |
LIG_SH2_STAT5 | 265 | 268 | PF00017 | 0.636 |
LIG_SH2_STAT5 | 80 | 83 | PF00017 | 0.359 |
LIG_SH3_3 | 89 | 95 | PF00018 | 0.412 |
LIG_SH3_3 | 9 | 15 | PF00018 | 0.670 |
LIG_SUMO_SIM_anti_2 | 206 | 216 | PF11976 | 0.606 |
LIG_TYR_ITIM | 24 | 29 | PF00017 | 0.529 |
MOD_CDK_SPK_2 | 8 | 13 | PF00069 | 0.707 |
MOD_CK1_1 | 172 | 178 | PF00069 | 0.522 |
MOD_CK1_1 | 221 | 227 | PF00069 | 0.727 |
MOD_CK1_1 | 238 | 244 | PF00069 | 0.657 |
MOD_CK1_1 | 53 | 59 | PF00069 | 0.503 |
MOD_CK2_1 | 149 | 155 | PF00069 | 0.467 |
MOD_CK2_1 | 205 | 211 | PF00069 | 0.663 |
MOD_Cter_Amidation | 291 | 294 | PF01082 | 0.776 |
MOD_GlcNHglycan | 140 | 143 | PF01048 | 0.485 |
MOD_GlcNHglycan | 151 | 154 | PF01048 | 0.302 |
MOD_GlcNHglycan | 171 | 174 | PF01048 | 0.689 |
MOD_GlcNHglycan | 2 | 5 | PF01048 | 0.722 |
MOD_GlcNHglycan | 223 | 226 | PF01048 | 0.755 |
MOD_GlcNHglycan | 246 | 249 | PF01048 | 0.713 |
MOD_GlcNHglycan | 52 | 55 | PF01048 | 0.449 |
MOD_GSK3_1 | 14 | 21 | PF00069 | 0.535 |
MOD_GSK3_1 | 168 | 175 | PF00069 | 0.578 |
MOD_GSK3_1 | 217 | 224 | PF00069 | 0.726 |
MOD_GSK3_1 | 231 | 238 | PF00069 | 0.452 |
MOD_LATS_1 | 202 | 208 | PF00433 | 0.610 |
MOD_NEK2_1 | 102 | 107 | PF00069 | 0.519 |
MOD_NEK2_1 | 160 | 165 | PF00069 | 0.551 |
MOD_NEK2_2 | 196 | 201 | PF00069 | 0.721 |
MOD_PIKK_1 | 160 | 166 | PF00454 | 0.579 |
MOD_PIKK_1 | 251 | 257 | PF00454 | 0.795 |
MOD_PKA_2 | 203 | 209 | PF00069 | 0.617 |
MOD_PKA_2 | 239 | 245 | PF00069 | 0.616 |
MOD_Plk_1 | 102 | 108 | PF00069 | 0.517 |
MOD_Plk_4 | 117 | 123 | PF00069 | 0.568 |
MOD_Plk_4 | 14 | 20 | PF00069 | 0.454 |
MOD_Plk_4 | 196 | 202 | PF00069 | 0.686 |
MOD_ProDKin_1 | 263 | 269 | PF00069 | 0.757 |
MOD_ProDKin_1 | 8 | 14 | PF00069 | 0.658 |
TRG_DiLeu_BaEn_1 | 155 | 160 | PF01217 | 0.604 |
TRG_DiLeu_BaLyEn_6 | 92 | 97 | PF01217 | 0.411 |
TRG_ENDOCYTIC_2 | 140 | 143 | PF00928 | 0.516 |
TRG_ENDOCYTIC_2 | 26 | 29 | PF00928 | 0.527 |
TRG_ER_diArg_1 | 287 | 290 | PF00400 | 0.653 |
TRG_ER_diArg_1 | 293 | 295 | PF00400 | 0.639 |
TRG_NES_CRM1_1 | 119 | 132 | PF08389 | 0.549 |
TRG_Pf-PMV_PEXEL_1 | 62 | 66 | PF00026 | 0.531 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I0R9 | Leptomonas seymouri | 65% | 98% |
A0A0S4IT31 | Bodo saltans | 26% | 100% |
A0A1X0NWE2 | Trypanosomatidae | 38% | 100% |
A0A3R7MR43 | Trypanosoma rangeli | 38% | 100% |
A0A3S7WYL9 | Leishmania donovani | 86% | 98% |
A4I119 | Leishmania infantum | 85% | 98% |
C9ZW91 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 38% | 100% |
E9AX56 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 85% | 99% |
Q4QAC0 | Leishmania major | 84% | 100% |
V5AV25 | Trypanosoma cruzi | 39% | 98% |